549 Results of a prospective phase I/II randomized trial of peptide-specific vaccination in HLA-A*0201 positive prostate carcinoma patients with biochemical recurrence after radical prostatectomy
| Autor: | C.M. Avilés Escobar, H.-G. Rammensee, Joerg Hennenlotter, Stefan Stevanovic, Susan Feyerabend, H. Griesemann, Cécile Gouttefangeas, M. Widenmeyer, Jens Bedke, A. Stenzl, K. Laske |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Oncology
Biochemical recurrence chemistry.chemical_classification medicine.medical_specialty business.industry Prostatectomy Urology medicine.medical_treatment Hla a 0201 Peptide Prostate carcinoma law.invention Vaccination Phase i ii Randomized controlled trial chemistry law Internal medicine medicine business |
| Zdroj: | European Urology Supplements. 15:e549 |
| ISSN: | 1569-9056 |
| DOI: | 10.1016/s1569-9056(16)60551-1 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect